Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde
About Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Clinical Trials at Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde
During the past decade, Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2014-09-18
2018-01-29
Terminated
906
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)
2016-07-21
2018-01-31
Terminated
994
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
2018-09-05
2021-09-03
Completed
940
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema
2020-08-05
2023-08-18
Active, not recruiting
1,479
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde
According to Clinical.Site data, the most researched conditions in "Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde" are
"Diabetic Macular Edema" (2 trials) and "Geographic Atrophy" (2 trials). Many other conditions were trialed in "Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde" in a lesser frequency.
Clinical Trials Intervention Types at Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde
Most popular intervention types in "Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde" are "Drug" (4 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (2 trials), "Lampalizumab" (2 trials), "Sham Procedure" (2 trials), "Aflibercept" (1 trials) and "Sham" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde
The vast majority of trials in "Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde" are
4 trials for "All" genders.
Clinical Trials Status at Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde
Currently, there are NaN active trials in "Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Kepler Universitätskliniken GmbH - Med Campus III; Abt. für Augenheilkunde, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".